← All Veradermics, INC filings

Veradermics, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
MANE
Veradermics, INC
10-Q: Veradermics Reports Positive Trial Data, Raises Capital
Veradermics, Inc. announced positive topline data for its VDPHL01 drug in pattern hair loss trials and significant capital raises, while also detailing substantial operating expenses and future funding needs.
NYSE
MANE
Veradermics, INC
10-Q: Veradermics Reports Positive Phase 2/3 Data, Plans Further Development
Veradermics, Inc. announced positive topline data from its Study 302 evaluating VDPHL01 for pattern hair loss, showing statistically significant improvements in hair count and patient-reported outcomes.